Case number 2024-1878
Seagen Inc. v. Daiichi Sankyo, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 7, 2025 | 0 | SEAGEN INC. v. DAIICHI SANKYO, INC. [OPINION] [nonprecedential] (0) |
| Aug 21, 2025 | 58 | NOTICE OF ORAL ARGUMENT. Panel: 2510I. Case scheduled October 6, 2025. Response to Notice of Oral Argument due: 09/04/2025. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [1109738] [CDL] [Entered: 08/21/2025 03:41 PM] (2) |
| Apr 24, 2025 | 57 | The following conflict dates requested on behalf of Seagan Inc.'s client representative (see Doc. No. [54]) are not accepted at this time: 06/06/2025, 06/09/2025. Please review the Guidance on Oral Argument Scheduling Conflicts for more information. [1084805] [MJL] [Entered: 04/24/2025 10:15 AM] (0) |
| Apr 24, 2025 | 56 | The following conflict dates submitted by Sara Tonnies Horton for Seagen Inc. have been accepted by the court: 06/02/2025, 06/03/2025, 06/04/2025, 06/05/2025, 07/07/2025, 07/08/2025, 07/09/2025, 07/10/2025, 07/11/2025, 07/14/2025. [1084804] [MJL] [Entered: 04/24/2025 10:13 AM] (0) |
| Apr 24, 2025 | 55 | The following conflict dates submitted by Preston K. Ratliff, II for Daiichi Sankyo, Inc. have been accepted by the court: 08/04/2025, 08/05/2025, 08/06/2025, 08/07/2025, 08/08/2025, 08/11/2025, 09/02/2025, 09/03/2025, 09/04/2025, 09/05/2025. [1084797] [MJL] [Entered: 04/24/2025 10:08 AM] (0) |
| Apr 21, 2025 | 54 | Notice from Appellant Seagen Inc. regarding conflicts with oral argument. Service: 04/21/2024 by email. [1083983] [24-1878] [Sara Horton] [Entered: 04/21/2025 07:25 PM] (3) |
| Apr 21, 2025 | 53 | Notice from Appellee AstraZeneca Pharmaceuticals LP regarding conflicts with oral argument. Service: 04/21/2025 by email. [1083975] [24-1878] [Christopher Sipes] [Entered: 04/21/2025 06:27 PM] (2) |
| Apr 21, 2025 | 52 | Notice from Appellee Daiichi Sankyo, Inc. regarding conflicts with oral argument. Service: 04/21/2025 by email. [1083909] [24-1878] [Preston Ratliff] [Entered: 04/21/2025 04:09 PM] (4) |
| Apr 21, 2025 | 51 | Notice from Appellee Daiichi Sankyo, Inc. regarding conflicts with oral argument. Service: 04/21/2025 by email. [1083900] [24-1878] [Preston Ratliff] [Entered: 04/21/2025 04:02 PM] (4) |
| Apr 17, 2025 | 50 | Notice from Intervenor Coke Morgan Stewart regarding conflicts with oral argument. Service: 04/17/2025 by email. [1083334] [24-1878] [William LaMarca] [Entered: 04/17/2025 11:08 AM] (4) |
| Apr 14, 2025 | 49 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [1082389] [IMH] [Entered: 04/14/2025 02:52 PM] (1) |
| Mar 13, 2025 | 48 | Notice from Intervenor Coke Morgan Stewart of Withdrawal of Director's Counsel (Farheena Y. Rasheed). Service: 03/13/2025 by email. [1075022] [24-1878] [Shehla Wynne] [Entered: 03/13/2025 10:37 AM] (1) |
| Mar 11, 2025 | 47 | Notice from Appellee AstraZeneca Pharmaceuticals LP Notice of Withdrawal of Non-Principal Counsel. Service: 03/11/2025 by email. [1074694] [24-1878] [Adam Mitchell] [Entered: 03/11/2025 08:43 PM] (2) |
| Mar 5, 2025 | 45 | Entry of Appearance for William La Marca as counsel for Intervenor Coke Morgan Stewart. Service: 03/05/2025 by email. [1073336] [24-1878] [William LaMarca] [Entered: 03/05/2025 03:30 PM] (1) |
| Mar 3, 2025 | 46 | 6 paper copies of Doc. No. [40] received from Appellant Seagen Inc.. [1073351] [VDW] [Entered: 03/05/2025 03:55 PM] (0) |
| Feb 28, 2025 | 44 | 6 paper copies of Doc. No. [39], [23] received from Appellant Seagen Inc.. [1072841] [VDW] [Entered: 03/04/2025 11:39 AM] (0) |
| Feb 27, 2025 | 43 | 6 paper copies of Doc. No. [28] received from Appellees AstraZeneca Pharmaceuticals LP and Daiichi Sankyo, Inc.. [1072640] [VDW] [Entered: 03/03/2025 02:28 PM] (0) |
| Feb 27, 2025 | 42 | 6 paper copies of Doc. No. [33] received from Intervenor Coke Morgan Stewart. [1072604] [VDW] [Entered: 03/03/2025 01:26 PM] (0) |
| Feb 25, 2025 | 41 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [1071385] [IMH] [Entered: 02/25/2025 03:06 PM] (0) |
| Feb 20, 2025 | 40 | MODIFIED ENTRY: APPENDIX FILED by Appellant Seagen Inc. Service: 02/20/2025 by email. [1070495] --[Edited 02/25/2025 by IMH - Reason: compliance review complete] [Sara Horton] [Entered: 02/20/2025 06:46 PM] (2453) |
| Feb 13, 2025 | 39 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellant Seagen Inc. Service: 02/13/2025 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [1069196] --[Edited 02/19/2025 by IMH - Reason: compliance review complete] [Sara Horton] [Entered: 02/13/2025 04:26 PM] (37) |
| Jan 24, 2025 | 38 | Official caption revised to reflect Coke Morgan Stewart's correct title. (see attached). Service as of this date by the Clerk of Court. [1063389] [IMH] [Entered: 01/24/2025 01:07 PM] (2) |
| Jan 23, 2025 | 37 | Official caption revised to substitute Coke Morgan Stewart, Acting Under Secretary of Commerce for Intellectual Property and Acting Director of the United States Patent and Trademark Office, as intervenor. (see attached). Service as of this date by the Clerk of Court. [1062902] [IMH] [Entered: 01/23/2025 11:37 AM] (2) |
| Jan 6, 2025 | 36 | **TEXT ONLY** ORDER granting motion to extend time to file brief [35] filed by Appellant Seagen Inc. The reply brief is due 02/13/2025. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [1058907] [IMH] [Entered: 01/06/2025 01:51 PM] (0) |
| Jan 6, 2025 | 35 | MOTION of Appellant Seagen Inc. to extend the time to 02/13/2025 to file brief. Service: 01/06/2025 by email. [1058883] [24-1878] [Sara Horton] [Entered: 01/06/2025 12:51 PM] (10) |
| Jan 6, 2025 | 34 | This entry was made in error and has been removed from the docket. NOTICE OF NON-COMPLIANCE: The submission of Intervenor Derrick Brent, Intervenor Brief [33], is not in compliance with the rules of this court (see attached). Compliant document due on 01/14/2025. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [1058869] [IMH] [Entered: 01/06/2025 12:11 PM] (0) |
| Dec 24, 2024 | 33 | MODIFIED ENTRY: INTERVENOR BRIEF FILED by Intervenor Derrick Brent. Service: 12/24/2024 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [1056693] --[Edited 01/06/2025 by IMH - Reason: compliance review complete] [Shehla Wynne] [Entered: 12/24/2024 03:30 PM] (25) |
| Dec 17, 2024 | 32 | Official caption revised to reflect change in Acting Under Secretary of Commerce for Intellectual Property and Acting Director of the United States Patent and Trademark Office (see attached). Service as of this date by the Clerk of Court. [1054781] [IMH] [Entered: 12/17/2024 10:52 AM] (2) |
| Dec 5, 2024 | 31 | Entry of Appearance for Amy J. Nelson as counsel for Intervenor Katherine K. Vidal. Service: 12/05/2024 by email. [1052100] [24-1878] [Amy Nelson] [Entered: 12/05/2024 02:13 PM] (2) |
| Nov 19, 2024 | 30 | Docketing Statement for the Intervenor Katherine K. Vidal. Service: 11/19/2024 by email. [1048182] [24-1878] [Shehla Wynne] [Entered: 11/19/2024 02:17 PM] (2) |
| Nov 14, 2024 | 29 | ORDER filed granting motion for leave to intervene [25].The revised official caption is reflected in this order. The Director is directed to file a docketing statement no later than 14 days from the date of entry of this order, and the Director's brief is due within 40 days of the date of entry of this order. Seagen Inc.'s reply brief is due no later than 21 days after the date of service of the Director's brief. The Clerk of Court shall transmit a copy of this order to the merits panel assigned to this case. Service as of this date by the Clerk of Court. [1047042] [LMS] [Entered: 11/14/2024 01:56 PM] (2) |
| Nov 6, 2024 | 28 | MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellees AstraZeneca Pharmaceuticals LP and Daiichi Sankyo, Inc. Service: 11/06/2024 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [1045442] --[Edited 11/15/2024 by IMH - Reason: compliance review complete] [Preston Ratliff] [Entered: 11/06/2024 11:10 PM] (80) |
| Nov 6, 2024 | 27 | Amended Certificate of Interest for Appellee Daiichi Sankyo, Inc.. Service: 11/06/2024 by email. [1045441] [24-1878] [Preston Ratliff] [Entered: 11/06/2024 11:08 PM] (2) |
| Nov 6, 2024 | 26 | Entry of Appearance for Lucas L. Kressel as counsel for Appellee Daiichi Sankyo, Inc.. Service: 11/06/2024 by email. [1045440] [24-1878] [Preston Ratliff] [Entered: 11/06/2024 11:07 PM] (1) |
| Oct 31, 2024 | 25 | MOTION of Katherine K. Vidal, Director, U.S. Patent and Trademark Office for leave to intervene. Service: 10/31/2024 by email. [1043990] [24-1878] [Shehla Wynne] [Entered: 10/31/2024 02:37 PM] (5) |
| Oct 31, 2024 | 24 | Entry of Appearance for Shehla Wynne; Farheena Y. Rasheed; Peter J. Ayers; Mary L. Kelly as counsel for Katherine K. Vidal, Director, U.S. Patent and Trademark Office. Service: 10/31/2024 by email. [1043988] [24-1878] [Shehla Wynne] [Entered: 10/31/2024 02:35 PM] (2) |
| Sep 27, 2024 | 23 | MODIFIED ENTRY: OPENING BRIEF FILED by Appellant Seagen Inc. Service: 09/27/2024 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [1035578] --[Edited 10/07/2024 by IMH - Reason: compliance review complete] [Sara Horton] [Entered: 09/27/2024 04:05 PM] (384) |
| Aug 7, 2024 | 22 | **TEXT ONLY** ORDER granting motion to extend time to file brief [21] filed by Appellant Seagen Inc. The opening brief is due 09/27/2024. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [1023427] [JSP] [Entered: 08/07/2024 02:25 PM] (0) |
| Aug 7, 2024 | 21 | MOTION of Appellant Seagen Inc. to extend the time to 09/27/2024 to file brief. Service: 08/07/2024 by email. [1023326] [24-1878] [Sara Horton] [Entered: 08/07/2024 10:55 AM] (10) |
| Jul 19, 2024 | 20 | ORDER filed granting the motions [1010273-2] [8] to the following extent: The above-captioned appeals shall be considered companion cases and assigned to the same merits panel, the respec-tive due dates for briefing are unchanged, and Daiichi will not be granted extensions of time for its briefing. Service as of this date by the Clerk of Court. [1019167] [23-2424, 24-1878] [LMS] [Entered: 07/19/2024 03:15 PM] (3) |
| Jul 9, 2024 | 19 | Certified list received. Service: 07/08/2024 by email. Refer to Fed. Cir. R. 31 for calculating brief deadlines from service of the certified list. [1016460] [JSP] [Entered: 07/09/2024 03:05 PM] (94) |
| Jun 28, 2024 | 18 | REPLY of Appellees Daiichi Sankyo, Inc. and AstraZeneca Pharmaceuticals LP to response [17]. Service: 06/28/2024 by email. [1014402] [24-1878] [Preston Ratliff] [Entered: 06/28/2024 10:15 PM] (12) |
| Jun 21, 2024 | 17 | RESPONSE of Appellant Seagen Inc. to Doc No. [8]. Service: 06/21/2024 by email. [1012599] [24-1878] [Sara Horton] [Entered: 06/21/2024 03:47 PM] (22) |
| Jun 13, 2024 | 16 | Corrected Docketing Statement for the Appellee Daiichi Sankyo, Inc.. Service: 06/13/2024 by email. [1011030] [24-1878] [Preston Ratliff] [Entered: 06/13/2024 11:02 PM] (3) |
| Jun 13, 2024 | 15 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Daiichi Sankyo, Inc., Docketing Statement [14], is not in compliance with the rules of this court (see attached). Compliant document due on 06/21/2024. Service as of this date by the Clerk of Court. [1010810] [IMH] [Entered: 06/13/2024 10:17 AM] (2) |
| Jun 12, 2024 | 14 | Docketing Statement for the Appellee Daiichi Sankyo, Inc.. Service: 06/12/2024 by email. [1010732] [24-1878] This document is non-compliant. See Doc No.[15] [Preston Ratliff] [Entered: 06/12/2024 10:14 PM] (3) |
| Jun 12, 2024 | 13 | Docketing Statement for the Appellee AstraZeneca Pharmaceuticals LP. Service: 06/12/2024 by email. [1010728] [24-1878] [Christopher Sipes] [Entered: 06/12/2024 09:29 PM] (2) |
| Jun 12, 2024 | 12 | Docketing Statement for the Appellant Seagen Inc.. Service: 06/12/2024 by email. [1010546] [24-1878] [Sara Horton] [Entered: 06/12/2024 12:23 PM] (2) |
| Jun 12, 2024 | 11 | Notice of Related Case Information for Appellant Seagen Inc.. Service: 06/12/2024 by email. [1010543] [24-1878] [Sara Horton] [Entered: 06/12/2024 12:22 PM] (3) |
| Jun 12, 2024 | 10 | Certificate of Interest for Appellant Seagen Inc.. Service: 06/12/2024 by email. [1010541] [24-1878] [Sara Horton] [Entered: 06/12/2024 12:21 PM] (3) |
| Jun 12, 2024 | 9 | Entry of Appearance for Sara Tonnies Horton; Devon Edwards; Dane Sowers as counsel for Appellant Seagen Inc.. Service: 06/12/2024 by email. [1010537] [24-1878] [Sara Horton] [Entered: 06/12/2024 12:18 PM] (2) |
| Jun 11, 2024 | 8 | MOTION of Appellees Daiichi Sankyo, Inc. and AstraZeneca Pharmaceuticals LP to treat as companion cases. Service: 06/11/2024 by email. [1010413] [24-1878] [Preston Ratliff] [Entered: 06/11/2024 09:24 PM] (23) |
| Jun 11, 2024 | 7 | Notice of Related Case Information for Appellee Daiichi Sankyo, Inc.. Service: 06/11/2024 by email. [1010412] [24-1878] [Preston Ratliff] [Entered: 06/11/2024 09:22 PM] (3) |
| Jun 11, 2024 | 6 | Certificate of Interest for Appellee Daiichi Sankyo, Inc.. Service: 06/11/2024 by email. [1010411] [24-1878] [Preston Ratliff] [Entered: 06/11/2024 09:21 PM] (3) |
| Jun 11, 2024 | 5 | Entry of Appearance for Preston K. Ratliff II; Naveen Modi; Stephen B. Kinnaird; Igor V. Timofeyev; Daniel Zeilberger; Justin T. Fleischacker as counsel for Appellee Daiichi Sankyo, Inc.. Service: 06/11/2024 by email. [1010410] [24-1878] [Preston Ratliff] [Entered: 06/11/2024 09:19 PM] (2) |
| Jun 11, 2024 | 4 | Notice of Related Case Information for Appellee AstraZeneca Pharmaceuticals LP. Service: 06/11/2024 by email. [1010407] [24-1878] [Christopher Sipes] [Entered: 06/11/2024 08:49 PM] (3) |
| Jun 11, 2024 | 3 | Certificate of Interest for Appellee AstraZeneca Pharmaceuticals LP. Service: 06/11/2024 by email. [1010405] [24-1878] [Christopher Sipes] [Entered: 06/11/2024 08:47 PM] (3) |
| Jun 11, 2024 | 2 | Entry of Appearance for Christopher N. Sipes; R. Jason Fowler; Bradley K. Ervin; Nicholas L. Evoy; Adam W. Mitchell as counsel for Appellee AstraZeneca Pharmaceuticals LP. Service: 06/11/2024 by email. [1010402] [24-1878] [Christopher Sipes] [Entered: 06/11/2024 08:43 PM] (2) |
| May 29, 2024 | 1 | Appeal docketed. Received: 05/28/2024. [1007045] Entry of Appearance is due on 06/12/2024. Certificate of Interest is due on 06/12/2024. Docketing Statement is due on 06/12/2024. Certified List is due on 07/08/2024. [JSP] [Entered: 05/29/2024 09:52 AM] (0) |
